According to news from CoinWorld, on January 8, BIO Protocol announced a strategic partnership with CRISPR AI to jointly promote the future development of decentralized science (DeSci). This collaboration includes a strategic allocation of Nuclease DAO to the BIO Treasury, injecting new momentum into the cooperation between the two parties in the fields of gene editing and distributed scientific research. This initiative will accelerate the innovation process in the DeSci field. In addition, the major project of the BIO Protocol platform, Long COVID Labs ($COVID), will be exclusively launched on BIO Launchpad on January 9, 2025. This project is led by current and former researchers from Stanford University, aiming to accelerate the research progress of treatment for over 100 million long COVID patients through decentralized financing. BIO Protocol continues to strengthen its leadership position in the field of decentralized science through strategic partnerships and technological innovation, making its future development potential highly anticipated!